WASHINGTON -- The Food and Drug Administration on Friday approved a highly anticipated hepatitis C drug from Merck that is the first new treatment for the virus in 20 years. The first-of-its-kind pill, Victrelis...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA clears first new hepatitis C drug in 20 years
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account